This article is more than 5 years old. Information may no longer be current.

American Headache Society Annual Scientific Meeting highlights clinical, practice management updates

PHILADELPHIA — Healio Primary Care will provide comprehensive live coverage of the American Headache Society Annual Scientific Meeting, taking place from July 11 to July 14.

The conference will feature more than 80 discussions, including late-breaking trials involving potential migraine prevention treatments and the FDA-approved agents to prevent migraine — Aimovig, Ajovy and Emgality. In addition, data from more than 150 studies, including research on utilizing telemedicine to help patients with headache, treating the condition in pregnant women and identifying children and adolescents at risk for headache, are among those scheduled to be presented.

Bookmark the page at this link for meeting updates and to peruse our previous American Headache Society Annual Scientific Meeting coverage. Readers are also encouraged to follow developments on our Twitter accounts — @HealioFM and @HealioIM — and Facebook accounts @HealioFamilyMed and @HealioInternalMedicine. Those readers who have not already done so can also sign up for evening news wires which will feature the conference’s top headlines. – by Janel Miller